Skip to main content
Year archive

Alkem Laboratories Limited — 2020 filings

All 129 regulatory filings released by Alkem Laboratories Limited (ALKEM) in 2020, sourced directly from the official regulator.

129 Filings
2020 Period
2020 filings (129)
Filing Released Lang
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2020-12-28 English
In continuation of our letter dated 27th November, 2020 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this ....
Regulatory Filings
2020-12-28 English
Trading Window
Regulatory Filings
2020-12-28 English
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th December, ....
Regulatory Filings
2020-12-28 English
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated ....
Regulatory Filings
2020-12-03 English
Related Party Transactions
Regulatory Filings
2020-12-03 English
Copy of Newspaper Publication
AGM Information
2020-11-28 English
Pursuant to Regulation 30 and 47 read alongwith Schedule Ill of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"}, please find enclosed herewith ....
Regulatory Filings
2020-11-28 English
Shareholders meeting
Regulatory Filings
2020-11-27 English
In furtherance to our intimation dated 06.11. 2020, this is to inform you that pursuant to the provisions of Sec 110 and other applicable provisions, if any, of the Companies Act, 2013 ....
Regulatory Filings
2020-11-27 English
Trading Window
Regulatory Filings
2020-11-06 English
We refer to our earlier communication dated 28th September, 2020 regarding closure of trading window (for the purpose of financial results for the quarter and half year ended 30th September, ....
Regulatory Filings
2020-11-06 English
Updates
Regulatory Filings
2020-11-06 English
This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management ....
Regulatory Filings
2020-11-06 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q2FY21 and ....
Regulatory Filings
2020-11-06 English
Investor Presentation
Regulatory Filings
2020-11-06 English
In continuation of our letter dated 28th October, 2020 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2020-11-06 English
Financial Result Updates
Regulatory Filings
2020-11-06 English
Outcome of Board Meeting
Regulatory Filings
2020-11-06 English
The Board of Directors at its meeting held today i.e. 06th November, 2020, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th ....
Regulatory Filings
2020-11-06 English
Press Release
Regulatory Filings
2020-10-29 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2FY21 and ....
Regulatory Filings
2020-10-29 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve the Standalone and Consolidated ....
Regulatory Filings
2020-10-28 English
Board Meeting — Financial Results
Regulatory Filings
2020-10-28 English
In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary ....
Regulatory Filings
2020-10-16 English
With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2020-10-09 English
Trading Window
Regulatory Filings
2020-09-28 English
This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th September, ....
Regulatory Filings
2020-09-28 English
This is with reference to the 46th Annual General Meeting ('AGM') of the Company held on Tuesday, 18th August, 2020 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). ....
Regulatory Filings
2020-08-18 English
This is with reference to the 46th Annual General Meeting ('AGM') of the Company held on Tuesday, 18th August, 2020 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). ....
Regulatory Filings
2020-08-18 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2020-08-18 English
Trading Window
Regulatory Filings
2020-08-07 English
We refer to our earlier communication dated 25th June, 2020 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th June, 2020) starting from ....
Regulatory Filings
2020-08-07 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY21 earnings ....
Regulatory Filings
2020-08-07 English
Investor Presentation
Regulatory Filings
2020-08-07 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY21 earnings ....
Regulatory Filings
2020-08-07 English
Financial Result Updates
Regulatory Filings
2020-08-07 English
In continuation of our letter dated 27th July, 2020 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Regulatory Filings
2020-08-07 English
The Board of Directors at its meeting held today i.e. 07th August, 2020, has approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2020. ....
Regulatory Filings
2020-08-07 English
Outcome of Board Meeting
Regulatory Filings
2020-08-07 English
This is to intimate you that Alkem Laboratories Limited (the 'Company') has launched Favipiravir in India under the brand name 'Alfluenza' for the treatment of mild to moderate COVID-19. ....
Regulatory Filings
2020-08-05 English
Press Release
Regulatory Filings
2020-08-05 English
Press Release
Call Transcript
2020-07-28 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q1FY21 financial ....
Regulatory Filings
2020-07-28 English
Board Meeting — Financial Results
Regulatory Filings
2020-07-27 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2020 ,inter alia, to consider and approve the Standalone and Consolidated ....
Regulatory Filings
2020-07-27 English
Disclosure under SEBI Takeover Regulations
Audit Report / Information
2020-07-24 English
Compliance Status Certificate (in terms of SEBI Exemption Order) for the financial year ended March 31, 2020.
Regulatory Filings
2020-07-23 English
Copy of Newspaper Publication
Regulatory Filings
2020-07-17 English
Pursuant to Regulation 30 and 47 read alongwith Schedule Ill of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"}, please find enclosed herewith ....
Regulatory Filings
2020-07-17 English
Please find enclosed herewith the Notice of the 46th Annual General Meeting of the Company scheduled to be held on Tuesday, 18th August, 2020 at 11.00 a.m. through Video Conferencing (VC)/ ....
Regulatory Filings
2020-07-16 English
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated ....
Regulatory Filings
2020-06-25 English
Related Party Transactions
Regulatory Filings
2020-06-25 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2020-06-25 English
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th June, 2020 ....
Regulatory Filings
2020-06-25 English
Trading Window
Regulatory Filings
2020-06-25 English
Annual Disclosure
Regulatory Filings
2020-06-24 English
In terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Secretarial Compliance Report for the period ....
Regulatory Filings
2020-06-23 English
Updates
Regulatory Filings
2020-06-22 English
This is to inform you that the Board of Directors of the Company vide Circular Resolution passed today i.e 20th June, 2020 approved the closure of operations of its manufacturing facility ....
Regulatory Filings
2020-06-20 English
This is with reference to our letter dated 25th June, 2019 (the 'Application') wherein we intimated the National Stock Exchange of India Limited and BSE Limited (the 'Stock Exchanges') ....
Regulatory Filings
2020-06-17 English
Updates
Regulatory Filings
2020-06-17 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY20 and ....
Regulatory Filings
2020-06-05 English
Investor Presentation
Regulatory Filings
2020-06-05 English
Trading Window
Regulatory Filings
2020-06-05 English
We refer to our earlier communication dated 17th March, 2020 regarding closure of trading window (for the purpose of financial results for the quarter and year ended 31st March 2020) starting ....
Regulatory Filings
2020-06-05 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY20 and ....
Regulatory Filings
2020-06-05 English
Record Date
Regulatory Filings
2020-06-05 English
The Board of Directors at its meeting held today i.e. 05th June, 2020 has fixed 11th August, 2020 as the record date for the purposes of the Annual General Meeting and payment of final dividend. ....
Regulatory Filings
2020-06-05 English
The Board of Directors at its meeting held today i.e. 05th June, 2020, has, inter alia: 1. recommended a final dividend of Rs. 3/- (Rupees three only) per equity share of ....
Regulatory Filings
2020-06-05 English
Financial Result Updates
Regulatory Filings
2020-06-05 English
In continuation of our letter dated 26th May, 2020 and pursuant to Regulation 30 read with Regulation 33 of the SEBI LODR (''Listing Regulations'') the Board of Directors of the Company, ....
Regulatory Filings
2020-06-05 English
Outcome of Board Meeting
Annual Report
2020-06-05 English
The Board of Directors at its meeting held today i.e. 05th June, 2020, has, inter alia: 1. approved the Standalone and Consolidated Audited Financial Statements of the Company ....
Regulatory Filings
2020-06-05 English
Dividend
Regulatory Filings
2020-06-05 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2020-06-01 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-06-01 English
Press Release
Regulatory Filings
2020-05-27 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY20 and ....
Regulatory Filings
2020-05-27 English
Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on June 05, 2020, inter alia:1. To consider and approve the ....
Regulatory Filings
2020-05-26 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2020-05-26 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2020 ,inter alia, to consider and approve (i) to consider and ....
Regulatory Filings
2020-05-26 English
Press Release
Regulatory Filings
2020-05-12 English
In furtherance to the intimation captioned "US FDA Inspection at Alkem's manufacturing facility located at St. Louis, USA" dated 07th February, 2020, this is to inform you that US FDA has ....
Regulatory Filings
2020-05-12 English
With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2020-05-07 English
In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary ....
Regulatory Filings
2020-04-20 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2020-04-06 English
In continuation of our letter dated 05th March, 2020 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this ....
Regulatory Filings
2020-04-06 English
Press Release
Regulatory Filings
2020-03-30 English
In light of the current COVID -19 crisis, the Company has contributed INR 7 Crores to the Prime Minister's Citizen Assistance and Relief in Emergency Situations (PMCARES) Fund in support ....
Regulatory Filings
2020-03-30 English
News Verification
Regulatory Filings
2020-03-17 English
This is with reference to BSE letter dated March 16, 2020 seeking clarification in terms of the provisions of Regulation 30 of the Listing Regulations, 2015 with reference to the media ....
Regulatory Filings
2020-03-17 English
Trading Window
Regulatory Filings
2020-03-17 English
This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th March, ....
Regulatory Filings
2020-03-17 English
Press Release
Regulatory Filings
2020-03-13 English
In furtherance lo the intimation captioned "US FDA Inspection at Alkem''s manufacturing facility located at Baddi, India" dated 21 st February, 2020, this is to inform you that US FDA has ....
Regulatory Filings
2020-03-13 English
Cessation
Board/Management Information
2020-03-09 English
This is to inform you that the tenure of Mr. Akhouri Maheshwar Prasad, Independent Director of the Company shall expire on 15th March, 2020, and on completion of his tenure, he shall cease ....
Regulatory Filings
2020-03-09 English
Shareholders meeting
Proxy Solicitation & Information Statement
2020-03-05 English
In furtherance to our intimation dated 7th February,2020, this is to inform you that the Company is in the process of conducting postal ballot including voting by electronic means) for ....
Regulatory Filings
2020-03-05 English
Press Release
Legal Proceedings Report
2020-02-21 English
This is to inform you that US FDA had conducted an inspection at the Company's manufacturing facility located at Baddi, India from 17th February, 2020 to 21st February, 2020. At ....
Regulatory Filings
2020-02-21 English
Investor Presentation
Regulatory Filings
2020-02-07 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q3FY20 and ....
Regulatory Filings
2020-02-07 English
We wish to inform you that the board of directors ('Board') of Alkem Laboratories Limited (the 'Company'), at its meeting held today, i.e. on 07th February, 2020 has interalia: ....
Regulatory Filings
2020-02-07 English
Change in Director(s)
Regulatory Filings
2020-02-07 English
This is to inform you that pursuant to the provisions of the Companies Act, 2013, the Board at its meeting held today have decided to seek approval of the shareholders by way of postal ....
Regulatory Filings
2020-02-07 English
Updates
Regulatory Filings
2020-02-07 English
Trading Window
Regulatory Filings
2020-02-07 English
We refer to our earlier communication dated 23rd December, 2019 regarding closure of trading window (for the purpose of financial results for the quarter ended 31st December, 2019) starting ....
Regulatory Filings
2020-02-07 English
Dividend
Interim / Quarterly Report
2020-02-07 English
In continuation of our letter dated 29th January, 2020, the Board of Directors of the Company, at its meeting held today, i.e. 7th February, 2020 inter alia, has declared Interim Dividend ....
Regulatory Filings
2020-02-07 English
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company, at its meeting held on February 07, 2020, inter alia, has declared Interim Dividend of Rs. 22/- (Rupees ....
Regulatory Filings
2020-02-07 English
In continuation of our letter dated 29th January, 2020 and pursuant to Regulation 30 read with Regulation 33 of the SEBI (LODR) Regulations, 2015 (''Listing Regulations'') the Board of ....
Regulatory Filings
2020-02-07 English
We wish to inform you that the board of directors ('Board') of Alkem Laboratories Limited (the 'Company'), at its meeting held today, i.e. on 07th February, 2020 has interalia: ....
Regulatory Filings
2020-02-07 English
Pursuant to Reg 30 read with Reg 33 & 42 of the SEBI(LODR) Reg,2015,the Board of Directors, at its meeting held today, has inter alia: a.Approved the Standalone and Consolidated Unaudited ....
Regulatory Filings
2020-02-07 English
Change in Director(s)
Regulatory Filings
2020-02-07 English
Financial Result Updates
Regulatory Filings
2020-02-07 English
Outcome of Board Meeting
Regulatory Filings
2020-02-07 English
This is to inform you that US FDA had conducted an inspection of the Company's manufacturing facility located at St. Louis, USA from 27th January, 2020 to 06th February, 2020. ....
Regulatory Filings
2020-02-07 English
Press Release
Regulatory Filings
2020-02-07 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY20 and ....
Regulatory Filings
2020-01-30 English
Press Release
Regulatory Filings
2020-01-30 English
Record Date
Regulatory Filings
2020-01-29 English
The Board of Directors of the Company in its meeting to be held on 07th February, 2020 shall consider and approve Interim Dividend for the Financial Year 2019-2020.
Regulatory Filings
2020-01-29 English
Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 07, 2020, inter alia, to consider the following;1. To Consider ....
Regulatory Filings
2020-01-29 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2020-01-29 English
The record date for the purpose of payment of interim dividend for the Financial Year 2019-2020, would be Saturday, 15th February, 2020, subject to declaration of the said interim dividend ....
Regulatory Filings
2020-01-29 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 ,inter alia, to consider and approve (i) the Standalone and Consolidated ...
Regulatory Filings
2020-01-29 English